CDC’s Advisory Committee on Immunization Practices (ACIP) voted almost unanimously to support the Pfizer-BioNTech COVID-19 vaccine booster for individuals aged 12 to 17. As with adults, the recommendation applies to individuals who received the second dose at least five months in the past. ACIP also recommended that the CDC bolster its suggestion that adolescents between the…